CELIA
OREJA GUEVARA
Profesora asociada de Ciencias de la Salud
University of Hasselt
Hasselt, BélgicaPublications in collaboration with researchers from University of Hasselt (13)
2024
-
Examining the environmental risk factors of progressive-onset and relapsing-onset multiple sclerosis: recruitment challenges, potential bias, and statistical strategies
Journal of neurology, Vol. 271, Núm. 1, pp. 472-485
2023
-
Early non-disabling relapses are important predictors of disability accumulation in people with relapsing-remitting multiple sclerosis
Multiple sclerosis (Houndmills, Basingstoke, England), Vol. 29, Núm. 7, pp. 875-883
-
Expert opinion on the long-term use of cladribine tablets for multiple sclerosis: Systematic literature review of real-world evidence
Multiple Sclerosis and Related Disorders, Vol. 69
-
The risk of secondary progressive multiple sclerosis is geographically determined but modifiable
Brain : a journal of neurology, Vol. 146, Núm. 11, pp. 4633-4644
2022
-
Anti-SARS-CoV-2 vaccination in people with multiple sclerosis: Lessons learnt a year in
Frontiers in Immunology, Vol. 13
-
Corrigendum to Longitudinal machine learning modeling of MS patient trajectories improves predictions of disability progression: [Computer Methods and Programs in Biomedicine, Volume 208, (September 2021) 106180
Computer methods and programs in biomedicine
-
Efficacy and safety of ocrelizumab in patients with relapsing-remitting multiple sclerosis with suboptimal response to prior disease-modifying therapies: A primary analysis from the phase 3b CASTING single-arm, open-label trial
European Journal of Neurology, Vol. 29, Núm. 3, pp. 790-801
-
Using personalized prognosis in the treatment of relapsing multiple sclerosis: A practical guide
Frontiers in Immunology, Vol. 13
2021
-
Longitudinal machine learning modeling of MS patient trajectories improves predictions of disability progression
Computer Methods and Programs in Biomedicine, Vol. 208
2020
-
Delay from treatment start to full effect of immunotherapies for multiple sclerosis
Brain, Vol. 143, Núm. 9, pp. 2742-2756
2019
-
Best Practices for Long-Term Monitoring and Follow-Up of Alemtuzumab-Treated MS Patients in Real-World Clinical Settings
Frontiers in Neurology, Vol. 10
2018
-
Prolonged-release fampridine in multiple sclerosis: clinical data and real-world experience. Report of an expert meeting
Therapeutic Advances in Neurological Disorders, Vol. 11
2015
-
Can we offer more to patients with multiple sclerosis?
European Neurological Review, Vol. 10, Núm. 2, pp. 139-147